US Stock MarketDetailed Quotes
ICU SeaStar Medical
- 5.2800
- +1.1600+28.16%
Close Jun 20 16:00 ET
- 5.3600
- +0.0800+1.52%
Post 16:12 ET
15.93MMarket Cap-245P/E (TTM)
5.3600High4.1200Low396.04KVolume4.3000Open4.1200Pre Close1.93MTurnover13.69%Turnover RatioLossP/E (Static)3.02MShares42.922552wk High-3.58P/B15.28MFloat Cap3.250052wk Low--Dividend TTM2.89MShs Float550.0000Historical High--Div YieldTTM30.10%Amplitude3.2500Historical Low4.8650Avg Price1Lot Size
SeaStar Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -13.77%3.95M | 22.41%14.21M | -61.86%2.94M | 65.97%2.94M | 185.82%3.75M | 464.16%4.58M | 160.94%11.61M | 7.72M | 1.77M | 10.44%1.31M |
| Selling and administrative expenses | -20.98%2.25M | 19.10%8.24M | -60.26%1.87M | 75.53%1.83M | 143.44%1.74M | 523.85%2.85M | 310.93%6.92M | --4.7M | --1.04M | 9.82%716K |
| -General and administrative expense | -20.98%2.25M | 19.10%8.24M | -60.26%1.87M | 75.53%1.83M | 143.44%1.74M | 523.85%2.85M | 310.93%6.92M | --4.7M | --1.04M | 9.82%716K |
| Research and development costs | -1.91%1.7M | 138.63%5.97M | 30.30%1.08M | 52.27%1.11M | 236.74%2.01M | 387.32%1.73M | -9.51%2.5M | --825K | --727K | 11.19%596K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | --2.19M | ---- | ---- | ---- |
| Operating profit | 13.77%-3.95M | -22.41%-14.21M | 61.86%-2.94M | -65.97%-2.94M | -185.82%-3.75M | -464.16%-4.58M | -160.94%-11.61M | -7.72M | -1.77M | -10.44%-1.31M |
| Net non-operating interest income expense | 66.97%-143K | -71.59%-1.08M | -35.37%-199K | -82.11%-224K | -17.80%-225K | -156.21%-433K | -197.17%-630K | -147K | -123K | -2,022.22%-191K |
| Non-operating interest expense | -66.97%143K | 71.59%1.08M | 35.37%199K | 82.11%224K | 17.80%225K | 156.21%433K | 197.17%630K | --147K | --123K | 2,022.22%191K |
| Other net income (expense) | -313.26%-8.6M | -21,982.00%-10.94M | -1,173.72%-6.74M | -426,700.00%-4.27M | -48.25%311K | -8,952.17%-2.08M | -21.88%50K | -529K | 1K | 560.44%601K |
| Gain on sale of security | -313.26%-8.6M | -1,626.00%-763K | -212.69%-1.65M | --825K | -31.61%411K | -8,952.17%-2.08M | 285.19%50K | ---528K | ---- | --601K |
| Special income (charges) | ---- | ---4.95M | --0 | ---4.95M | ---- | ---- | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | --4.95M | --0 | --4.95M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---5.23M | ---5.09M | -14,300.00%-142K | ---100K | ---- | ---- | ---- | --1K | ---- |
| Income before tax | -78.93%-12.7M | -115.21%-26.23M | -17.73%-9.88M | -292.70%-7.43M | -306.21%-3.66M | -606.77%-7.1M | -165.15%-12.19M | -8.39M | -1.89M | 18.44%-902K |
| Income tax | 0 | 0 | -5K | 0 | 5K | 0 | 200.00%1K | 0 | 1K | 0 |
| Net income | -78.93%-12.7M | -115.19%-26.23M | -17.67%-9.88M | -292.49%-7.43M | -306.76%-3.67M | -606.77%-7.1M | -165.23%-12.19M | -8.39M | -1.89M | 18.44%-902K |
| Net income continuous Operations | -78.93%-12.7M | -115.19%-26.23M | -17.67%-9.88M | -292.49%-7.43M | -306.76%-3.67M | -606.77%-7.1M | -165.23%-12.19M | ---8.39M | ---1.89M | 18.44%-902K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -78.93%-12.7M | -115.19%-26.23M | -17.67%-9.88M | -292.49%-7.43M | -306.76%-3.67M | -606.77%-7.1M | -165.23%-12.19M | -8.39M | -1.89M | 18.44%-902K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -78.93%-12.7M | -115.19%-26.23M | -17.67%-9.88M | -292.49%-7.43M | -306.76%-3.67M | -606.77%-7.1M | -165.23%-12.19M | -8.39M | -1.89M | 18.44%-902K |
| Basic earnings per share | 64.81%-4.75 | 18.24%-30.25 | 68.62%-5.1848 | -148.35%-9.25 | -251.99%-6.25 | -583.05%-13.5 | -308.95%-37 | -16.5201 | -3.7245 | 18.44%-1.7756 |
| Diluted earnings per share | 64.81%-4.75 | 18.24%-30.25 | 68.62%-5.1848 | -148.35%-9.25 | -251.99%-6.25 | -583.05%-13.5 | -308.95%-37 | -16.5201 | -3.7245 | 18.44%-1.7756 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg